Medpace Holdings (MEDP) stock plummeted 7.21% to trade at $XXX on Tuesday amid the broader market sell-off. The healthcare company's shares were hit hard during the intraday trading session.
The decline came after Truist Financial analyst Jailendra Singh maintained a Hold rating on Medpace Holdings. While the analyst provided no specific price target, the reiterated Hold stance likely contributed to investor concerns over the company's near-term outlook.
Despite the sell-off, some analysts remain optimistic about Medpace's prospects in the healthcare sector. In separate notes, analysts highlighted Medpace as one of their top healthcare picks alongside companies like Incyte.